Medical University of Vienna

🇦🇹Austria

Country: 🇦🇹Austria

Ownership: Private

Established: 1365-01-01

Employees: 1K

Market Cap: -

Website: http://www.meduniwien.ac.at

Clinical Trials

Vaginal Progesterone in the Treatment of Cervical Dysplasia Grade I and II

Phase 2

Completed

Conditions: Cervical Intraepithelial Neoplasia

First Posted Date: 2005-11-01

Last Posted Date: 2012-03-09

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 40

Registration Number: NCT00247169

Locations: 🇦🇹
Dept OB/GYN, Med University of Vienna, Vienna, Austria

The Vienna Prograf and Endothelial Progenitor Cell Study

Phase 4

Completed

Conditions: End Stage Renal Disease

Interventions: Drug: Ciclosporin
Drug: Tacrolimus

First Posted Date: 2005-09-16

Last Posted Date: 2014-02-05

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 148

Registration Number: NCT00182559

Locations: 🇦🇹
Medical University of Vienna, Vienna, Austria

Omega-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Severe Chronic Heart Failure

Phase 2

Completed

Conditions: Chronic Heart Failure

Interventions: Dietary Supplement: Omacor

First Posted Date: 2005-09-08

Last Posted Date: 2010-07-13

Lead Sponsor: Medical University of Vienna

Registration Number: NCT00149409

Locations: 🇦🇹
Medical University of Vienna, Vienna, Austria

Treatment of Hepatocellular Carcinoma: Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin Alone

Phase 3

Conditions: Carcinoma, Hepatocellular

First Posted Date: 2005-07-21

Last Posted Date: 2005-10-18

Lead Sponsor: Medical University of Vienna

Target Recruit Count: 120

Registration Number: NCT00121914

Locations: 🇦🇹
Universitaetsklinik fuer Innere Medizin IV / Gastroenterologie und Hepatologie, Vienna, Austria

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy